Trump will unveil a deal with Regeneron to lower drug prices
President Donald Trump will announce a deal with Regeneron to lower the cost of its pharmaceutical products as part of the White House's most-favored-nation drug pricing initiative. Regeneron will lower prices on Medicaid and sell a cholesterol drug for $225 on TrumpRx.
President Donald Trump will announce a deal with Regeneron to lower pharmaceutical prices as part of the White House's most-favored-nation initiative. Regeneron will lower prices on current and future drugs for Medicaid and sell Praluent for $225 on TrumpRx. The deal is part of the Trump administration's efforts to provide economic relief ahead of the midterm elections. Regeneron will also invest nearly $10 billion to bring pharmaceutical production to the US. The company announced FDA approval for a new gene therapy, Otarmeni, which will be available at no charge. The Trump administration has made similar deals with other drug companies, but details have not been made public.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.